Research Highlights

Faculty Labs

Research Areas

Epilepsy

The National Association of Epilepsy Centers, which evaluates medical facilities on a regional, national and international basis, has designated UT Southwestern Medical Center as a Level 4 epilepsy center, which is the highest level. Our physicians and researchers are leaders in epilepsy drug research, electroencephalography (EEG) evaluation, brain mapping methods and operative EEG techniques.

Parkinson's Disease

UT Southwestern Medical Center's clinical and research programs for Parkinson's disease and other movement disorders were established to provide patients with some of the most advanced treatments available in the U.S. Our research activities receive funding from the National Institutes of Health, the American Parkinson's Disease Association (APDA), the Parkinson's Disease Foundation (PDF) and the Michael J. Fox Foundation.

Neuro-Oncology

The Annette G. Strauss Center for Neuro-Oncology is the cornerstone of UT Southwestern's Neuro-Oncology research. Its focus is to improve treatments available for patients – both inpatients and outpatients – and conduct research of tumors of the central nervous system, including benign and malignant brain and spinal-cord tumors.

Stroke-Neurovascular Disorders

Our researchers receive ongoing funding for numerous scientific studies in the fields of stroke, brain aneurysms and related disorders. UT Southwestern's groundbreaking research often leads to advancements in diagnostic techniques and treatments that assist with stroke assessment and recovery.

Funding Opportunities

Clinical Trials

Study Highlights

Principal Investigator: Dr. Nader Pouratian

Deep Brain Stimulation of the Subgenual Cingulate Cortex in the Treatment of Chronic Medically Refractory Low Back Pain (Study details)

Principal Investigator: Dr. Toral Patel

A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine (CCNU) or temozolomide (TMZ) in patients undergoing planned resection for first recurrence glioblastoma. (Study details)

Principal Investigator: Dr. Alex Valadka

Transforming Research and Clinical Knowledge in Traumatic Brain Injury II (TRACK-TBI II) (Study details)

Principal Investigator: Dr. Babu Welch

Chronic Subdural Hematoma Treatment with Embolization Versus Surgery Study

Principal Investigator: Dr. Jonathan White

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Two Doses of REC-994 (Study details)

Trials Database

To find a specific trial or learn more about our other research search our clinical trials database.

Search Clinical Trials.

Neurosurgery Research Group (NRG)

NRG is the department's central research team, with experienced personnel dedicated to providing comprehensive support and expert services for all human research related activities in the department, including:

Handling initial IRB submissions, modifications, annual updates, and continuing reviews
Obtaining necessary ancillary approvals for study start-up, including those from the Clinical Research Unit, Radiology, Investigative Drug Services, Coverage Analysis, Value Analysis, etc.
Screening, consenting and enrolling research participants
NRG personnel are certified by the institution to perform vitals, EKGs, phlebotomy, and to process blood samples
NRG personnel are certified to conduct standard neurological assessments (modified Rankin Scale, NIH Stroke Scale, MoCA) and a wide range of study-specific neurological assessments
Financial management of studies, including budget negotiations and research billing activities
Creating and maintaining regulatory binders
Providing training to and assisting in the credentialing of research study personnel
FDA IDE submissions and annual reports
Managing clinical trial agreements and other study contracting

For requests or inquiries, please contact Tash Mupambo, Clinical Research Operations Lead, at tashinga.mupambo@utsouthwestern.edu.